As a UKbased medical clinician and weight loss specialist, I have seen how two powerful tools can support better outcomes for patients: Whether you are exploring Mounjaro, Wegovy or Saxenda, or are already on HRT, understanding how these treatments can complement each other is key to making informed, effective health decisions
These may include: Carpal tunnel syndrome: Long-term elevation of growth hormone levels may lead to symptoms associated with carpal tunnel syndrome, such as numbness or tingling in the hands and fingers
CapsiAtra (Dihydrocapsiate)
Dietary habits, physical activity levels, concurrent medications, and undiagnosed conditions like hypothyroidism can impair GLP-1 effectiveness
Pictured: Woman grasping her stomach in pain/iStock, Doucefleur The use of glucagon-like peptide 1 (GLP-1) agonists for weight loss, such as Novo Nordisks Ozempic and Wegovy, is associated with the risk of gastrointestinal adverse events, according to a study published Thursday in the medical journal JAMA
Phytochemicals as anti-inflammatory agents in animal models of prevalent inflammatory diseases
